Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays
- PMID: 11861402
Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays
Abstract
Squamous cell carcinomas of the head and neck constitute an anatomically heterogeneous group of neoplasms that share in common a causal association with tobacco and alcohol exposure. The clinical course of these neoplasms is difficult to predict based on established prognostic clinicopathological criteria. Given the genetic complexity of head and neck cancers, it is not surprising that correlations with individual genetic abnormalities have also been disappointing. Several authors have suggested that global gene expression patterns can be used to subgroup patients with cancer. Here we report the use of cDNA microarrays containing 9216 clones to measure global patterns of gene expression in these neoplasms. We have used a statistical algorithm to identify 375 genes, which divide patients with head and neck tumors into two clinically distinct subgroups based on gene expression patterns. Our results demonstrate that gene expression profiling can be used as a predictor of outcome.
Similar articles
-
Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.Int J Oncol. 2006 Sep;29(3):605-13. Int J Oncol. 2006. PMID: 16865276
-
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.Cancer Cell. 2004 May;5(5):489-500. doi: 10.1016/s1535-6108(04)00112-6. Cancer Cell. 2004. PMID: 15144956
-
Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.Cancer Res. 2005 Apr 15;65(8):3063-71. doi: 10.1158/0008-5472.CAN-04-1985. Cancer Res. 2005. PMID: 15833835
-
Is gene expression profiling of head and neck cancers ready for the clinic?Biomark Med. 2010 Aug;4(4):571-80. doi: 10.2217/bmm.10.71. Biomark Med. 2010. PMID: 20701444 Review.
-
Role of molecular markers and gene profiling in head and neck cancers.Curr Opin Oncol. 2009 May;21(3):206-11. doi: 10.1097/CCO.0b013e328329ac00. Curr Opin Oncol. 2009. PMID: 19346943 Review.
Cited by
-
Identify and validate circadian regulators as potential prognostic markers and immune infiltrates in head and neck squamous cell carcinoma.Sci Rep. 2023 Nov 15;13(1):19939. doi: 10.1038/s41598-023-46560-8. Sci Rep. 2023. PMID: 37968308 Free PMC article.
-
Metabolism-associated molecular classification and prognosis signature of head and neck squamous cell carcinoma.Heliyon. 2024 Mar 7;10(6):e27587. doi: 10.1016/j.heliyon.2024.e27587. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38501009 Free PMC article.
-
Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.Clin Cancer Res. 2009 Mar 1;15(5):1645-54. doi: 10.1158/1078-0432.CCR-08-2581. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240170 Free PMC article.
-
Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma.Clin Cancer Res. 2013 Oct 1;19(19):5444-55. doi: 10.1158/1078-0432.CCR-12-3280. Epub 2013 Jul 26. Clin Cancer Res. 2013. PMID: 23894057 Free PMC article.
-
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.Am J Pathol. 2009 Mar;174(3):736-45. doi: 10.2353/ajpath.2009.080731. Epub 2009 Jan 29. Am J Pathol. 2009. PMID: 19179615 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical